News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

5 Things Celgene Corporation (CELG)'s Management Wants You To Know



8/11/2014 2:55:09 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A little more than two weeks ago biotech giant Celgene (NASDAQ: CELG ) delivered another smashing success of a quarter, at least along the lines of what the initial numbers entailed.

For the quarter, Celgene, which has been expanding the indications of existing medications in its product portfolio while also advancing its pipeline and introducing new therapies to pharmacy shelves, reported a 17% increase in total revenue to $1.87 billion from $1.6 billion in the year-ago period, while adjusted earnings per share increased 18% to $0.90 from $0.76.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES